Benutzer: Gast  Login
Titel:

PD-1 Blockade Elicits Ongoing Remission in Two Cases of Refractory Microsatellite-Stable Cancer Harboring a POLE Mutation.

Dokumenttyp:
Case Reports
Autor(en):
Schenck, Kristina; Masetti, Michael; Pfarr, Nicole; Lorenzen, Sylvie
Abstract:
INTRODUCTION: In the last decade, immune-checkpoint therapy has led to a break-through in the treatment of cancer across all entities, while molecular markers have grown in importance for the choice of the appropriate chemotherapeutic agents. Accordingly, in 2017, the US Food and Drug Administration approved the programmed cell death protein 1 inhibitor pembrolizumab, a tissue agnostic cancer drug, for the treatment of cancer that displays microsatellite instability, regardless of histological e...     »
Zeitschriftentitel:
Oncology Research and Treatment
Jahr:
2022
Band / Volume:
45
Heft / Issue:
4
Seitenangaben Beitrag:
222-226
Volltext / DOI:
doi:10.1159/000521332
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/34875656
Print-ISSN:
2296-5270
TUM Einrichtung:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie); Institut für Allgemeine Pathologie und Pathologische Anatomie
 BibTeX